Literature DB >> 31907743

Testing a model of fear of cancer recurrence or progression: the central role of intrusions, death anxiety and threat appraisal.

L Curran1,2, L Sharpe3, C MacCann3, P Butow3,4,5.   

Abstract

We recently proposed a model of cancer-related anxiety to account for the etiology and maintenance of clinically significant anxiety in the context of cancer. This study tested predictions arising from the model to explain fear of cancer recurrence or progression (FCR). Patients with cancer were recruited from a research registry or outpatient hospital clinics (n = 211). In bivariate analyses, FCR was associated with metacognitive beliefs, intolerance of uncertainty, core belief disruption, less meaning in life, social constraints, death anxiety, intrusions, threat appraisal, and coping. A hierarchical regression explained 65% of the variance in FCR. FCR was predicted by younger age, intrusions, death anxiety, threat appraisal and meta-cognitions. The findings highlight the importance of both cognitive processes and content in FCR, including intrusions, fears about death and dying, beliefs about worry, and threat appraisals.

Entities:  

Keywords:  Cancer; Cognitive processing; Death anxiety; Fear of recurrence; Theoretical model

Year:  2020        PMID: 31907743     DOI: 10.1007/s10865-019-00129-x

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  58 in total

1.  Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence.

Authors:  P Butow; S Kelly; B Thewes; G Hruby; L Sharpe; J Beith
Journal:  Psychooncology       Date:  2014-08-25       Impact factor: 3.894

2.  Multicollinearity in Regression Analyses Conducted in Epidemiologic Studies.

Authors:  Kristina P Vatcheva; MinJae Lee; Joseph B McCormick; Mohammad H Rahbar
Journal:  Epidemiology (Sunnyvale)       Date:  2016-03-07

3.  Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial.

Authors:  Marieke van de Wal; Belinda Thewes; Marieke Gielissen; Anne Speckens; Judith Prins
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

Review 4.  Making sense of the meaning literature: an integrative review of meaning making and its effects on adjustment to stressful life events.

Authors:  Crystal L Park
Journal:  Psychol Bull       Date:  2010-03       Impact factor: 17.737

5.  An Acceptance and Commitment Therapy (ACT) group intervention for cancer survivors experiencing anxiety at re-entry.

Authors:  Joanna J Arch; Jill L Mitchell
Journal:  Psychooncology       Date:  2015-06-29       Impact factor: 3.894

6.  Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer.

Authors:  Peter Herschbach; Petra Berg; Sabine Waadt; Gabriele Duran; Ursula Engst-Hastreiter; Gerhard Henrich; Katrin Book; Andreas Dinkel
Journal:  Psychother Psychosom       Date:  2009-11-04       Impact factor: 17.659

7.  Breast and ovarian cancer survivors' experience of participating in a cognitive-existential group intervention addressing fear of cancer recurrence.

Authors:  Christine Maheu; Sophie Lebel; Christina Tomei; Mina Singh; Mary Jane Esplen
Journal:  Eur J Oncol Nurs       Date:  2014-12-30       Impact factor: 2.398

8.  Screening and comorbidity of clinical levels of fear of cancer recurrence.

Authors:  Sébastien Simard; Josée Savard
Journal:  J Cancer Surviv       Date:  2015-01-21       Impact factor: 4.442

9.  Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors.

Authors:  B Thewes; M L Bell; P Butow
Journal:  Psychooncology       Date:  2013-02-13       Impact factor: 3.894

10.  Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.

Authors:  Christine Maheu; Sophie Lebel; Christine Courbasson; Monique Lefebvre; Mina Singh; Lori J Bernstein; Linda Muraca; Aronela Benea; Lynne Jolicoeur; Cheryl Harris; Agnihotram V Ramanakumar; Sarah Ferguson; Souraya Sidani
Journal:  BMC Cancer       Date:  2016-04-25       Impact factor: 4.430

View more
  5 in total

Review 1.  What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?

Authors:  Steffen T Simon; Anne Pralong; Michael Hallek; Christoph Scheid; Udo Holtick; Marco Herling
Journal:  Ann Hematol       Date:  2021-05-06       Impact factor: 3.673

2.  Posttraumatic growth and its association with unmet supportive care needs and fear of cancer progression among head and neck cancer patients.

Authors:  Nik Ruzyanei Nik Jaafar; Nur Amirah Hamdan; Norhaliza Abd Hamid; Rama Krsna Rajandram; Raynuha Mahadevan; Hazli Zakaria; Mohd Razif Mohamad Yunus; Mohammad Farris Iman Leong Bin Abdullah
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.240

3.  At the heart of the COVID-19 crisis: Perceived concerns of changes in long-term cancer care in French women with cancer.

Authors:  Claire Della Vecchia; Magali Girodet; Stéphéline Ginguené; Camille Carpentier; Tanguy Leroy; Arnaud Siméone; Emilie Vayre; Xavier Mabire; Dulce Ferraz; Christine Morin-Messabel; Marie Préau
Journal:  Eur J Cancer Care (Engl)       Date:  2022-05-06       Impact factor: 2.328

Review 4.  Fear of Recurrence of Atrial Fibrillation: Translating a Cancer Fear Model to the Atrial Fibrillation Patient Experience.

Authors:  Scarlett Anthony; Rebecca Harrell; Caroline Martin; Taylor Hawkins; Saleen Khan; Aditi Naniwadekar; Samuel F Sears
Journal:  Front Psychiatry       Date:  2022-07-04       Impact factor: 5.435

5.  Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma.

Authors:  Fiona A Lynch; Lynda Katona; Michael Jefford; Allan Ben Smith; Joanne Shaw; Haryana M Dhillon; Steve Ellen; Jo Phipps-Nelson; Julia Lai-Kwon; Donna Milne; Lahiru Russell; Victoria Dax; Justine Diggens; Holly Kent; Alison Button-Sloan; Jane Elliott; Mark Shackleton; Hayley Burridge; Maria Ftanou
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.